Global Fosfomycin Sodium Market

Fosfomycin Sodium Comprehensive Study by Type (Tablets, Injection), Application (Common Urinary Tract Infection, Postoperative Urinary Tract Infection, Preoperative Prevention of Urinary Tract Infection), Distribution Channel (Online, Medical Stores, Pharmaceuticals), End-User (Hospital Pharmacy, Retail Pharmacies, Electronic Pharmacy) Players and Region - Global Market Outlook to 2030

Fosfomycin Sodium Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 3.6%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Fosfomycin Sodium Market Scope?
Fosfomycin is a phosphoenolpyruvate analog and a synthetic broad-spectrum antibiotic with antimicrobial and bactericidal properties. Fosfomycin binds to the enzyme enol pyruvate transferase and inactivates it. This leads to an irreversible blocking of the condensation of uridine diphosphate-N-acetylglucosamine with p-enol pyruvate, which is one of the first steps in bacterial cell wall synthesis and ultimately leads to cell lysis and bacterial cell death. Fosfomycin is an orally available broad-spectrum antibiotic that is mainly used to treat uncomplicated urinary tract infections. Fosfomycin is associated with jaundice with a low rate of transient serum enzymes during therapy and with rare cases of clinically apparent acute liver damage.

Influencing Trend:
Increasing Healthcare Spending and Demand for Drug Therapy

Market Growth Drivers:
Growing Geriatric Population in Major Economies, Growing Cases of Urinary Tract Infections and Increase in the Unhygienic Conditions of Toilets

Challenges:
Availability of Substitute Drugs in the Market

Restraints:
Stringent Government Rules and Regulation and Side Effects Due to Fosfomycin Sodium

Opportunities:
R&D and Product Innovation and Potential Growth From Emerging Countries

The Fosfomycin Sodium market study is being classified by Type (Tablets and Injection), by Application and major geographies with country level break-up.

The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Analysts at AMA predicts that Players from Asian will contribute to the maximum growth of Global Fosfomycin Sodium market throughout the predicted period.

Merck Group (Germany), AdvaCare Pharma (United States), LGM Pharma (United States), Cipla (India), Northeast Pharmaceutical Group Co. Ltd. (China), Ercros (Spain), SGPharma Pvt. Ltd. (India), Shin Poong Pharm Co. Ltd. (South Korea), Sundent Pharm Group (China) and Hubei Xunda Pharmaceutical (China) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are FarmaSino Pharmaceutical (China) and National Analytical Corporation (India).

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Fosfomycin Sodium market by Type, Application and Region.

On the basis of geography, the market of Fosfomycin Sodium has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Influencers and their Development Strategies
In October 2023, Hikma Pharmaceuticals launched Fosmicin IV (fosfomycin trometamol for injection) in the US market, expanding access to this important antibiotic for treating multidrug-resistant (MDR) Gram-negative bacterial infections.
In December 2023, Spero Therapeutics received FDA approval for Orbactiv (omadacycline), a new tetracycline antibiotic indicated for complicated urinary tract infections (cUTI) and acute bacterial skin and skin structure infections (ABSSSI). Omadacycline has a similar mechanism of action to Fosfomycin Sodium,


Key Target Audience
Manufacturers of Fosfomycin Sodium, Suppliers and Distributors of Fosfomycin Sodium, End-Users, Potential Investors, Market Research Firms, Regulatory Bodies and Others

Fosfomycin Sodium Market Study: Important Years
AttributesDetails
Study Period2018-2030
Base Year2023
Forecast Period2024-2030
Historical Period2018-2023
UnitValue (USD Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Major Highlights of Market Study

Demand Determinants: Identifying top-notch application and business segments that seek high growth potentials in Fosfomycin Sodium Market.

Key Strategic Developments: To target untapped regions more aggressively by focusing on product/service developments, innovation and R & D, new launches, Merger & acquisitions, JVs & partnerships.

Forces & Market Dynamics: Growth drivers, restraints & opportunities available in Fosfomycin Sodium industry is examined with reference relevant market sectors and sub-sectors.

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also includes significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets, To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Type
  • Tablets
  • Injection
By Application
  • Common Urinary Tract Infection
  • Postoperative Urinary Tract Infection
  • Preoperative Prevention of Urinary Tract Infection
By Distribution Channel
  • Online
  • Medical Stores
  • Pharmaceuticals

By End-User
  • Hospital Pharmacy
  • Retail Pharmacies
  • Electronic Pharmacy

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Geriatric Population in Major Economies
      • 3.2.2. Growing Cases of Urinary Tract Infections
      • 3.2.3. Increase in the Unhygienic Conditions of Toilets
    • 3.3. Market Challenges
      • 3.3.1. Availability of Substitute Drugs in the Market
    • 3.4. Market Trends
      • 3.4.1. Increasing Healthcare Spending and Demand for Drug Therapy
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Fosfomycin Sodium, by Type, Application, Distribution Channel, End-User and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Fosfomycin Sodium (Value)
      • 5.2.1. Global Fosfomycin Sodium by: Type (Value)
        • 5.2.1.1. Tablets
        • 5.2.1.2. Injection
      • 5.2.2. Global Fosfomycin Sodium by: Application (Value)
        • 5.2.2.1. Common Urinary Tract Infection
        • 5.2.2.2. Postoperative Urinary Tract Infection
        • 5.2.2.3. Preoperative Prevention of Urinary Tract Infection
      • 5.2.3. Global Fosfomycin Sodium by: Distribution Channel (Value)
        • 5.2.3.1. Online
        • 5.2.3.2. Medical Stores
        • 5.2.3.3. Pharmaceuticals
      • 5.2.4. Global Fosfomycin Sodium by: End-User (Value)
        • 5.2.4.1. Hospital Pharmacy
        • 5.2.4.2. Retail Pharmacies
        • 5.2.4.3. Electronic Pharmacy
      • 5.2.5. Global Fosfomycin Sodium Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Fosfomycin Sodium (Volume)
      • 5.3.1. Global Fosfomycin Sodium by: Type (Volume)
        • 5.3.1.1. Tablets
        • 5.3.1.2. Injection
      • 5.3.2. Global Fosfomycin Sodium by: Application (Volume)
        • 5.3.2.1. Common Urinary Tract Infection
        • 5.3.2.2. Postoperative Urinary Tract Infection
        • 5.3.2.3. Preoperative Prevention of Urinary Tract Infection
      • 5.3.3. Global Fosfomycin Sodium by: Distribution Channel (Volume)
        • 5.3.3.1. Online
        • 5.3.3.2. Medical Stores
        • 5.3.3.3. Pharmaceuticals
      • 5.3.4. Global Fosfomycin Sodium by: End-User (Volume)
        • 5.3.4.1. Hospital Pharmacy
        • 5.3.4.2. Retail Pharmacies
        • 5.3.4.3. Electronic Pharmacy
      • 5.3.5. Global Fosfomycin Sodium Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Fosfomycin Sodium (Price)
      • 5.4.1. Global Fosfomycin Sodium by: Type (Price)
  • 6. Fosfomycin Sodium: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Merck Group (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. AdvaCare Pharma (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. LGM Pharma (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Cipla (India)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Northeast Pharmaceutical Group Co. Ltd. (China)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Ercros (Spain)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. SGPharma Pvt. Ltd. (India)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Shin Poong Pharm Co. Ltd. (South Korea)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Sundent Pharm Group (China)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Hubei Xunda Pharmaceutical (China)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Fosfomycin Sodium Sale, by Type, Application, Distribution Channel, End-User and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Fosfomycin Sodium (Value)
      • 7.2.1. Global Fosfomycin Sodium by: Type (Value)
        • 7.2.1.1. Tablets
        • 7.2.1.2. Injection
      • 7.2.2. Global Fosfomycin Sodium by: Application (Value)
        • 7.2.2.1. Common Urinary Tract Infection
        • 7.2.2.2. Postoperative Urinary Tract Infection
        • 7.2.2.3. Preoperative Prevention of Urinary Tract Infection
      • 7.2.3. Global Fosfomycin Sodium by: Distribution Channel (Value)
        • 7.2.3.1. Online
        • 7.2.3.2. Medical Stores
        • 7.2.3.3. Pharmaceuticals
      • 7.2.4. Global Fosfomycin Sodium by: End-User (Value)
        • 7.2.4.1. Hospital Pharmacy
        • 7.2.4.2. Retail Pharmacies
        • 7.2.4.3. Electronic Pharmacy
      • 7.2.5. Global Fosfomycin Sodium Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Fosfomycin Sodium (Volume)
      • 7.3.1. Global Fosfomycin Sodium by: Type (Volume)
        • 7.3.1.1. Tablets
        • 7.3.1.2. Injection
      • 7.3.2. Global Fosfomycin Sodium by: Application (Volume)
        • 7.3.2.1. Common Urinary Tract Infection
        • 7.3.2.2. Postoperative Urinary Tract Infection
        • 7.3.2.3. Preoperative Prevention of Urinary Tract Infection
      • 7.3.3. Global Fosfomycin Sodium by: Distribution Channel (Volume)
        • 7.3.3.1. Online
        • 7.3.3.2. Medical Stores
        • 7.3.3.3. Pharmaceuticals
      • 7.3.4. Global Fosfomycin Sodium by: End-User (Volume)
        • 7.3.4.1. Hospital Pharmacy
        • 7.3.4.2. Retail Pharmacies
        • 7.3.4.3. Electronic Pharmacy
      • 7.3.5. Global Fosfomycin Sodium Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Fosfomycin Sodium (Price)
      • 7.4.1. Global Fosfomycin Sodium by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Fosfomycin Sodium: by Type(USD Million)
  • Table 2. Fosfomycin Sodium Tablets , by Region USD Million (2018-2023)
  • Table 3. Fosfomycin Sodium Injection , by Region USD Million (2018-2023)
  • Table 4. Fosfomycin Sodium: by Application(USD Million)
  • Table 5. Fosfomycin Sodium Common Urinary Tract Infection , by Region USD Million (2018-2023)
  • Table 6. Fosfomycin Sodium Postoperative Urinary Tract Infection , by Region USD Million (2018-2023)
  • Table 7. Fosfomycin Sodium Preoperative Prevention of Urinary Tract Infection , by Region USD Million (2018-2023)
  • Table 8. Fosfomycin Sodium: by Distribution Channel(USD Million)
  • Table 9. Fosfomycin Sodium Online , by Region USD Million (2018-2023)
  • Table 10. Fosfomycin Sodium Medical Stores , by Region USD Million (2018-2023)
  • Table 11. Fosfomycin Sodium Pharmaceuticals , by Region USD Million (2018-2023)
  • Table 12. Fosfomycin Sodium: by End-User(USD Million)
  • Table 13. Fosfomycin Sodium Hospital Pharmacy , by Region USD Million (2018-2023)
  • Table 14. Fosfomycin Sodium Retail Pharmacies , by Region USD Million (2018-2023)
  • Table 15. Fosfomycin Sodium Electronic Pharmacy , by Region USD Million (2018-2023)
  • Table 16. South America Fosfomycin Sodium, by Country USD Million (2018-2023)
  • Table 17. South America Fosfomycin Sodium, by Type USD Million (2018-2023)
  • Table 18. South America Fosfomycin Sodium, by Application USD Million (2018-2023)
  • Table 19. South America Fosfomycin Sodium, by Distribution Channel USD Million (2018-2023)
  • Table 20. South America Fosfomycin Sodium, by End-User USD Million (2018-2023)
  • Table 21. Brazil Fosfomycin Sodium, by Type USD Million (2018-2023)
  • Table 22. Brazil Fosfomycin Sodium, by Application USD Million (2018-2023)
  • Table 23. Brazil Fosfomycin Sodium, by Distribution Channel USD Million (2018-2023)
  • Table 24. Brazil Fosfomycin Sodium, by End-User USD Million (2018-2023)
  • Table 25. Argentina Fosfomycin Sodium, by Type USD Million (2018-2023)
  • Table 26. Argentina Fosfomycin Sodium, by Application USD Million (2018-2023)
  • Table 27. Argentina Fosfomycin Sodium, by Distribution Channel USD Million (2018-2023)
  • Table 28. Argentina Fosfomycin Sodium, by End-User USD Million (2018-2023)
  • Table 29. Rest of South America Fosfomycin Sodium, by Type USD Million (2018-2023)
  • Table 30. Rest of South America Fosfomycin Sodium, by Application USD Million (2018-2023)
  • Table 31. Rest of South America Fosfomycin Sodium, by Distribution Channel USD Million (2018-2023)
  • Table 32. Rest of South America Fosfomycin Sodium, by End-User USD Million (2018-2023)
  • Table 33. Asia Pacific Fosfomycin Sodium, by Country USD Million (2018-2023)
  • Table 34. Asia Pacific Fosfomycin Sodium, by Type USD Million (2018-2023)
  • Table 35. Asia Pacific Fosfomycin Sodium, by Application USD Million (2018-2023)
  • Table 36. Asia Pacific Fosfomycin Sodium, by Distribution Channel USD Million (2018-2023)
  • Table 37. Asia Pacific Fosfomycin Sodium, by End-User USD Million (2018-2023)
  • Table 38. China Fosfomycin Sodium, by Type USD Million (2018-2023)
  • Table 39. China Fosfomycin Sodium, by Application USD Million (2018-2023)
  • Table 40. China Fosfomycin Sodium, by Distribution Channel USD Million (2018-2023)
  • Table 41. China Fosfomycin Sodium, by End-User USD Million (2018-2023)
  • Table 42. Japan Fosfomycin Sodium, by Type USD Million (2018-2023)
  • Table 43. Japan Fosfomycin Sodium, by Application USD Million (2018-2023)
  • Table 44. Japan Fosfomycin Sodium, by Distribution Channel USD Million (2018-2023)
  • Table 45. Japan Fosfomycin Sodium, by End-User USD Million (2018-2023)
  • Table 46. India Fosfomycin Sodium, by Type USD Million (2018-2023)
  • Table 47. India Fosfomycin Sodium, by Application USD Million (2018-2023)
  • Table 48. India Fosfomycin Sodium, by Distribution Channel USD Million (2018-2023)
  • Table 49. India Fosfomycin Sodium, by End-User USD Million (2018-2023)
  • Table 50. South Korea Fosfomycin Sodium, by Type USD Million (2018-2023)
  • Table 51. South Korea Fosfomycin Sodium, by Application USD Million (2018-2023)
  • Table 52. South Korea Fosfomycin Sodium, by Distribution Channel USD Million (2018-2023)
  • Table 53. South Korea Fosfomycin Sodium, by End-User USD Million (2018-2023)
  • Table 54. Taiwan Fosfomycin Sodium, by Type USD Million (2018-2023)
  • Table 55. Taiwan Fosfomycin Sodium, by Application USD Million (2018-2023)
  • Table 56. Taiwan Fosfomycin Sodium, by Distribution Channel USD Million (2018-2023)
  • Table 57. Taiwan Fosfomycin Sodium, by End-User USD Million (2018-2023)
  • Table 58. Australia Fosfomycin Sodium, by Type USD Million (2018-2023)
  • Table 59. Australia Fosfomycin Sodium, by Application USD Million (2018-2023)
  • Table 60. Australia Fosfomycin Sodium, by Distribution Channel USD Million (2018-2023)
  • Table 61. Australia Fosfomycin Sodium, by End-User USD Million (2018-2023)
  • Table 62. Rest of Asia-Pacific Fosfomycin Sodium, by Type USD Million (2018-2023)
  • Table 63. Rest of Asia-Pacific Fosfomycin Sodium, by Application USD Million (2018-2023)
  • Table 64. Rest of Asia-Pacific Fosfomycin Sodium, by Distribution Channel USD Million (2018-2023)
  • Table 65. Rest of Asia-Pacific Fosfomycin Sodium, by End-User USD Million (2018-2023)
  • Table 66. Europe Fosfomycin Sodium, by Country USD Million (2018-2023)
  • Table 67. Europe Fosfomycin Sodium, by Type USD Million (2018-2023)
  • Table 68. Europe Fosfomycin Sodium, by Application USD Million (2018-2023)
  • Table 69. Europe Fosfomycin Sodium, by Distribution Channel USD Million (2018-2023)
  • Table 70. Europe Fosfomycin Sodium, by End-User USD Million (2018-2023)
  • Table 71. Germany Fosfomycin Sodium, by Type USD Million (2018-2023)
  • Table 72. Germany Fosfomycin Sodium, by Application USD Million (2018-2023)
  • Table 73. Germany Fosfomycin Sodium, by Distribution Channel USD Million (2018-2023)
  • Table 74. Germany Fosfomycin Sodium, by End-User USD Million (2018-2023)
  • Table 75. France Fosfomycin Sodium, by Type USD Million (2018-2023)
  • Table 76. France Fosfomycin Sodium, by Application USD Million (2018-2023)
  • Table 77. France Fosfomycin Sodium, by Distribution Channel USD Million (2018-2023)
  • Table 78. France Fosfomycin Sodium, by End-User USD Million (2018-2023)
  • Table 79. Italy Fosfomycin Sodium, by Type USD Million (2018-2023)
  • Table 80. Italy Fosfomycin Sodium, by Application USD Million (2018-2023)
  • Table 81. Italy Fosfomycin Sodium, by Distribution Channel USD Million (2018-2023)
  • Table 82. Italy Fosfomycin Sodium, by End-User USD Million (2018-2023)
  • Table 83. United Kingdom Fosfomycin Sodium, by Type USD Million (2018-2023)
  • Table 84. United Kingdom Fosfomycin Sodium, by Application USD Million (2018-2023)
  • Table 85. United Kingdom Fosfomycin Sodium, by Distribution Channel USD Million (2018-2023)
  • Table 86. United Kingdom Fosfomycin Sodium, by End-User USD Million (2018-2023)
  • Table 87. Netherlands Fosfomycin Sodium, by Type USD Million (2018-2023)
  • Table 88. Netherlands Fosfomycin Sodium, by Application USD Million (2018-2023)
  • Table 89. Netherlands Fosfomycin Sodium, by Distribution Channel USD Million (2018-2023)
  • Table 90. Netherlands Fosfomycin Sodium, by End-User USD Million (2018-2023)
  • Table 91. Rest of Europe Fosfomycin Sodium, by Type USD Million (2018-2023)
  • Table 92. Rest of Europe Fosfomycin Sodium, by Application USD Million (2018-2023)
  • Table 93. Rest of Europe Fosfomycin Sodium, by Distribution Channel USD Million (2018-2023)
  • Table 94. Rest of Europe Fosfomycin Sodium, by End-User USD Million (2018-2023)
  • Table 95. MEA Fosfomycin Sodium, by Country USD Million (2018-2023)
  • Table 96. MEA Fosfomycin Sodium, by Type USD Million (2018-2023)
  • Table 97. MEA Fosfomycin Sodium, by Application USD Million (2018-2023)
  • Table 98. MEA Fosfomycin Sodium, by Distribution Channel USD Million (2018-2023)
  • Table 99. MEA Fosfomycin Sodium, by End-User USD Million (2018-2023)
  • Table 100. Middle East Fosfomycin Sodium, by Type USD Million (2018-2023)
  • Table 101. Middle East Fosfomycin Sodium, by Application USD Million (2018-2023)
  • Table 102. Middle East Fosfomycin Sodium, by Distribution Channel USD Million (2018-2023)
  • Table 103. Middle East Fosfomycin Sodium, by End-User USD Million (2018-2023)
  • Table 104. Africa Fosfomycin Sodium, by Type USD Million (2018-2023)
  • Table 105. Africa Fosfomycin Sodium, by Application USD Million (2018-2023)
  • Table 106. Africa Fosfomycin Sodium, by Distribution Channel USD Million (2018-2023)
  • Table 107. Africa Fosfomycin Sodium, by End-User USD Million (2018-2023)
  • Table 108. North America Fosfomycin Sodium, by Country USD Million (2018-2023)
  • Table 109. North America Fosfomycin Sodium, by Type USD Million (2018-2023)
  • Table 110. North America Fosfomycin Sodium, by Application USD Million (2018-2023)
  • Table 111. North America Fosfomycin Sodium, by Distribution Channel USD Million (2018-2023)
  • Table 112. North America Fosfomycin Sodium, by End-User USD Million (2018-2023)
  • Table 113. United States Fosfomycin Sodium, by Type USD Million (2018-2023)
  • Table 114. United States Fosfomycin Sodium, by Application USD Million (2018-2023)
  • Table 115. United States Fosfomycin Sodium, by Distribution Channel USD Million (2018-2023)
  • Table 116. United States Fosfomycin Sodium, by End-User USD Million (2018-2023)
  • Table 117. Canada Fosfomycin Sodium, by Type USD Million (2018-2023)
  • Table 118. Canada Fosfomycin Sodium, by Application USD Million (2018-2023)
  • Table 119. Canada Fosfomycin Sodium, by Distribution Channel USD Million (2018-2023)
  • Table 120. Canada Fosfomycin Sodium, by End-User USD Million (2018-2023)
  • Table 121. Mexico Fosfomycin Sodium, by Type USD Million (2018-2023)
  • Table 122. Mexico Fosfomycin Sodium, by Application USD Million (2018-2023)
  • Table 123. Mexico Fosfomycin Sodium, by Distribution Channel USD Million (2018-2023)
  • Table 124. Mexico Fosfomycin Sodium, by End-User USD Million (2018-2023)
  • Table 125. Fosfomycin Sodium Sales: by Type(K Tons)
  • Table 126. Fosfomycin Sodium Sales Tablets , by Region K Tons (2018-2023)
  • Table 127. Fosfomycin Sodium Sales Injection , by Region K Tons (2018-2023)
  • Table 128. Fosfomycin Sodium Sales: by Application(K Tons)
  • Table 129. Fosfomycin Sodium Sales Common Urinary Tract Infection , by Region K Tons (2018-2023)
  • Table 130. Fosfomycin Sodium Sales Postoperative Urinary Tract Infection , by Region K Tons (2018-2023)
  • Table 131. Fosfomycin Sodium Sales Preoperative Prevention of Urinary Tract Infection , by Region K Tons (2018-2023)
  • Table 132. Fosfomycin Sodium Sales: by Distribution Channel(K Tons)
  • Table 133. Fosfomycin Sodium Sales Online , by Region K Tons (2018-2023)
  • Table 134. Fosfomycin Sodium Sales Medical Stores , by Region K Tons (2018-2023)
  • Table 135. Fosfomycin Sodium Sales Pharmaceuticals , by Region K Tons (2018-2023)
  • Table 136. Fosfomycin Sodium Sales: by End-User(K Tons)
  • Table 137. Fosfomycin Sodium Sales Hospital Pharmacy , by Region K Tons (2018-2023)
  • Table 138. Fosfomycin Sodium Sales Retail Pharmacies , by Region K Tons (2018-2023)
  • Table 139. Fosfomycin Sodium Sales Electronic Pharmacy , by Region K Tons (2018-2023)
  • Table 140. South America Fosfomycin Sodium Sales, by Country K Tons (2018-2023)
  • Table 141. South America Fosfomycin Sodium Sales, by Type K Tons (2018-2023)
  • Table 142. South America Fosfomycin Sodium Sales, by Application K Tons (2018-2023)
  • Table 143. South America Fosfomycin Sodium Sales, by Distribution Channel K Tons (2018-2023)
  • Table 144. South America Fosfomycin Sodium Sales, by End-User K Tons (2018-2023)
  • Table 145. Brazil Fosfomycin Sodium Sales, by Type K Tons (2018-2023)
  • Table 146. Brazil Fosfomycin Sodium Sales, by Application K Tons (2018-2023)
  • Table 147. Brazil Fosfomycin Sodium Sales, by Distribution Channel K Tons (2018-2023)
  • Table 148. Brazil Fosfomycin Sodium Sales, by End-User K Tons (2018-2023)
  • Table 149. Argentina Fosfomycin Sodium Sales, by Type K Tons (2018-2023)
  • Table 150. Argentina Fosfomycin Sodium Sales, by Application K Tons (2018-2023)
  • Table 151. Argentina Fosfomycin Sodium Sales, by Distribution Channel K Tons (2018-2023)
  • Table 152. Argentina Fosfomycin Sodium Sales, by End-User K Tons (2018-2023)
  • Table 153. Rest of South America Fosfomycin Sodium Sales, by Type K Tons (2018-2023)
  • Table 154. Rest of South America Fosfomycin Sodium Sales, by Application K Tons (2018-2023)
  • Table 155. Rest of South America Fosfomycin Sodium Sales, by Distribution Channel K Tons (2018-2023)
  • Table 156. Rest of South America Fosfomycin Sodium Sales, by End-User K Tons (2018-2023)
  • Table 157. Asia Pacific Fosfomycin Sodium Sales, by Country K Tons (2018-2023)
  • Table 158. Asia Pacific Fosfomycin Sodium Sales, by Type K Tons (2018-2023)
  • Table 159. Asia Pacific Fosfomycin Sodium Sales, by Application K Tons (2018-2023)
  • Table 160. Asia Pacific Fosfomycin Sodium Sales, by Distribution Channel K Tons (2018-2023)
  • Table 161. Asia Pacific Fosfomycin Sodium Sales, by End-User K Tons (2018-2023)
  • Table 162. China Fosfomycin Sodium Sales, by Type K Tons (2018-2023)
  • Table 163. China Fosfomycin Sodium Sales, by Application K Tons (2018-2023)
  • Table 164. China Fosfomycin Sodium Sales, by Distribution Channel K Tons (2018-2023)
  • Table 165. China Fosfomycin Sodium Sales, by End-User K Tons (2018-2023)
  • Table 166. Japan Fosfomycin Sodium Sales, by Type K Tons (2018-2023)
  • Table 167. Japan Fosfomycin Sodium Sales, by Application K Tons (2018-2023)
  • Table 168. Japan Fosfomycin Sodium Sales, by Distribution Channel K Tons (2018-2023)
  • Table 169. Japan Fosfomycin Sodium Sales, by End-User K Tons (2018-2023)
  • Table 170. India Fosfomycin Sodium Sales, by Type K Tons (2018-2023)
  • Table 171. India Fosfomycin Sodium Sales, by Application K Tons (2018-2023)
  • Table 172. India Fosfomycin Sodium Sales, by Distribution Channel K Tons (2018-2023)
  • Table 173. India Fosfomycin Sodium Sales, by End-User K Tons (2018-2023)
  • Table 174. South Korea Fosfomycin Sodium Sales, by Type K Tons (2018-2023)
  • Table 175. South Korea Fosfomycin Sodium Sales, by Application K Tons (2018-2023)
  • Table 176. South Korea Fosfomycin Sodium Sales, by Distribution Channel K Tons (2018-2023)
  • Table 177. South Korea Fosfomycin Sodium Sales, by End-User K Tons (2018-2023)
  • Table 178. Taiwan Fosfomycin Sodium Sales, by Type K Tons (2018-2023)
  • Table 179. Taiwan Fosfomycin Sodium Sales, by Application K Tons (2018-2023)
  • Table 180. Taiwan Fosfomycin Sodium Sales, by Distribution Channel K Tons (2018-2023)
  • Table 181. Taiwan Fosfomycin Sodium Sales, by End-User K Tons (2018-2023)
  • Table 182. Australia Fosfomycin Sodium Sales, by Type K Tons (2018-2023)
  • Table 183. Australia Fosfomycin Sodium Sales, by Application K Tons (2018-2023)
  • Table 184. Australia Fosfomycin Sodium Sales, by Distribution Channel K Tons (2018-2023)
  • Table 185. Australia Fosfomycin Sodium Sales, by End-User K Tons (2018-2023)
  • Table 186. Rest of Asia-Pacific Fosfomycin Sodium Sales, by Type K Tons (2018-2023)
  • Table 187. Rest of Asia-Pacific Fosfomycin Sodium Sales, by Application K Tons (2018-2023)
  • Table 188. Rest of Asia-Pacific Fosfomycin Sodium Sales, by Distribution Channel K Tons (2018-2023)
  • Table 189. Rest of Asia-Pacific Fosfomycin Sodium Sales, by End-User K Tons (2018-2023)
  • Table 190. Europe Fosfomycin Sodium Sales, by Country K Tons (2018-2023)
  • Table 191. Europe Fosfomycin Sodium Sales, by Type K Tons (2018-2023)
  • Table 192. Europe Fosfomycin Sodium Sales, by Application K Tons (2018-2023)
  • Table 193. Europe Fosfomycin Sodium Sales, by Distribution Channel K Tons (2018-2023)
  • Table 194. Europe Fosfomycin Sodium Sales, by End-User K Tons (2018-2023)
  • Table 195. Germany Fosfomycin Sodium Sales, by Type K Tons (2018-2023)
  • Table 196. Germany Fosfomycin Sodium Sales, by Application K Tons (2018-2023)
  • Table 197. Germany Fosfomycin Sodium Sales, by Distribution Channel K Tons (2018-2023)
  • Table 198. Germany Fosfomycin Sodium Sales, by End-User K Tons (2018-2023)
  • Table 199. France Fosfomycin Sodium Sales, by Type K Tons (2018-2023)
  • Table 200. France Fosfomycin Sodium Sales, by Application K Tons (2018-2023)
  • Table 201. France Fosfomycin Sodium Sales, by Distribution Channel K Tons (2018-2023)
  • Table 202. France Fosfomycin Sodium Sales, by End-User K Tons (2018-2023)
  • Table 203. Italy Fosfomycin Sodium Sales, by Type K Tons (2018-2023)
  • Table 204. Italy Fosfomycin Sodium Sales, by Application K Tons (2018-2023)
  • Table 205. Italy Fosfomycin Sodium Sales, by Distribution Channel K Tons (2018-2023)
  • Table 206. Italy Fosfomycin Sodium Sales, by End-User K Tons (2018-2023)
  • Table 207. United Kingdom Fosfomycin Sodium Sales, by Type K Tons (2018-2023)
  • Table 208. United Kingdom Fosfomycin Sodium Sales, by Application K Tons (2018-2023)
  • Table 209. United Kingdom Fosfomycin Sodium Sales, by Distribution Channel K Tons (2018-2023)
  • Table 210. United Kingdom Fosfomycin Sodium Sales, by End-User K Tons (2018-2023)
  • Table 211. Netherlands Fosfomycin Sodium Sales, by Type K Tons (2018-2023)
  • Table 212. Netherlands Fosfomycin Sodium Sales, by Application K Tons (2018-2023)
  • Table 213. Netherlands Fosfomycin Sodium Sales, by Distribution Channel K Tons (2018-2023)
  • Table 214. Netherlands Fosfomycin Sodium Sales, by End-User K Tons (2018-2023)
  • Table 215. Rest of Europe Fosfomycin Sodium Sales, by Type K Tons (2018-2023)
  • Table 216. Rest of Europe Fosfomycin Sodium Sales, by Application K Tons (2018-2023)
  • Table 217. Rest of Europe Fosfomycin Sodium Sales, by Distribution Channel K Tons (2018-2023)
  • Table 218. Rest of Europe Fosfomycin Sodium Sales, by End-User K Tons (2018-2023)
  • Table 219. MEA Fosfomycin Sodium Sales, by Country K Tons (2018-2023)
  • Table 220. MEA Fosfomycin Sodium Sales, by Type K Tons (2018-2023)
  • Table 221. MEA Fosfomycin Sodium Sales, by Application K Tons (2018-2023)
  • Table 222. MEA Fosfomycin Sodium Sales, by Distribution Channel K Tons (2018-2023)
  • Table 223. MEA Fosfomycin Sodium Sales, by End-User K Tons (2018-2023)
  • Table 224. Middle East Fosfomycin Sodium Sales, by Type K Tons (2018-2023)
  • Table 225. Middle East Fosfomycin Sodium Sales, by Application K Tons (2018-2023)
  • Table 226. Middle East Fosfomycin Sodium Sales, by Distribution Channel K Tons (2018-2023)
  • Table 227. Middle East Fosfomycin Sodium Sales, by End-User K Tons (2018-2023)
  • Table 228. Africa Fosfomycin Sodium Sales, by Type K Tons (2018-2023)
  • Table 229. Africa Fosfomycin Sodium Sales, by Application K Tons (2018-2023)
  • Table 230. Africa Fosfomycin Sodium Sales, by Distribution Channel K Tons (2018-2023)
  • Table 231. Africa Fosfomycin Sodium Sales, by End-User K Tons (2018-2023)
  • Table 232. North America Fosfomycin Sodium Sales, by Country K Tons (2018-2023)
  • Table 233. North America Fosfomycin Sodium Sales, by Type K Tons (2018-2023)
  • Table 234. North America Fosfomycin Sodium Sales, by Application K Tons (2018-2023)
  • Table 235. North America Fosfomycin Sodium Sales, by Distribution Channel K Tons (2018-2023)
  • Table 236. North America Fosfomycin Sodium Sales, by End-User K Tons (2018-2023)
  • Table 237. United States Fosfomycin Sodium Sales, by Type K Tons (2018-2023)
  • Table 238. United States Fosfomycin Sodium Sales, by Application K Tons (2018-2023)
  • Table 239. United States Fosfomycin Sodium Sales, by Distribution Channel K Tons (2018-2023)
  • Table 240. United States Fosfomycin Sodium Sales, by End-User K Tons (2018-2023)
  • Table 241. Canada Fosfomycin Sodium Sales, by Type K Tons (2018-2023)
  • Table 242. Canada Fosfomycin Sodium Sales, by Application K Tons (2018-2023)
  • Table 243. Canada Fosfomycin Sodium Sales, by Distribution Channel K Tons (2018-2023)
  • Table 244. Canada Fosfomycin Sodium Sales, by End-User K Tons (2018-2023)
  • Table 245. Mexico Fosfomycin Sodium Sales, by Type K Tons (2018-2023)
  • Table 246. Mexico Fosfomycin Sodium Sales, by Application K Tons (2018-2023)
  • Table 247. Mexico Fosfomycin Sodium Sales, by Distribution Channel K Tons (2018-2023)
  • Table 248. Mexico Fosfomycin Sodium Sales, by End-User K Tons (2018-2023)
  • Table 249. Fosfomycin Sodium: by Type(USD/Units)
  • Table 250. Company Basic Information, Sales Area and Its Competitors
  • Table 251. Company Basic Information, Sales Area and Its Competitors
  • Table 252. Company Basic Information, Sales Area and Its Competitors
  • Table 253. Company Basic Information, Sales Area and Its Competitors
  • Table 254. Company Basic Information, Sales Area and Its Competitors
  • Table 255. Company Basic Information, Sales Area and Its Competitors
  • Table 256. Company Basic Information, Sales Area and Its Competitors
  • Table 257. Company Basic Information, Sales Area and Its Competitors
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Company Basic Information, Sales Area and Its Competitors
  • Table 260. Fosfomycin Sodium: by Type(USD Million)
  • Table 261. Fosfomycin Sodium Tablets , by Region USD Million (2025-2030)
  • Table 262. Fosfomycin Sodium Injection , by Region USD Million (2025-2030)
  • Table 263. Fosfomycin Sodium: by Application(USD Million)
  • Table 264. Fosfomycin Sodium Common Urinary Tract Infection , by Region USD Million (2025-2030)
  • Table 265. Fosfomycin Sodium Postoperative Urinary Tract Infection , by Region USD Million (2025-2030)
  • Table 266. Fosfomycin Sodium Preoperative Prevention of Urinary Tract Infection , by Region USD Million (2025-2030)
  • Table 267. Fosfomycin Sodium: by Distribution Channel(USD Million)
  • Table 268. Fosfomycin Sodium Online , by Region USD Million (2025-2030)
  • Table 269. Fosfomycin Sodium Medical Stores , by Region USD Million (2025-2030)
  • Table 270. Fosfomycin Sodium Pharmaceuticals , by Region USD Million (2025-2030)
  • Table 271. Fosfomycin Sodium: by End-User(USD Million)
  • Table 272. Fosfomycin Sodium Hospital Pharmacy , by Region USD Million (2025-2030)
  • Table 273. Fosfomycin Sodium Retail Pharmacies , by Region USD Million (2025-2030)
  • Table 274. Fosfomycin Sodium Electronic Pharmacy , by Region USD Million (2025-2030)
  • Table 275. South America Fosfomycin Sodium, by Country USD Million (2025-2030)
  • Table 276. South America Fosfomycin Sodium, by Type USD Million (2025-2030)
  • Table 277. South America Fosfomycin Sodium, by Application USD Million (2025-2030)
  • Table 278. South America Fosfomycin Sodium, by Distribution Channel USD Million (2025-2030)
  • Table 279. South America Fosfomycin Sodium, by End-User USD Million (2025-2030)
  • Table 280. Brazil Fosfomycin Sodium, by Type USD Million (2025-2030)
  • Table 281. Brazil Fosfomycin Sodium, by Application USD Million (2025-2030)
  • Table 282. Brazil Fosfomycin Sodium, by Distribution Channel USD Million (2025-2030)
  • Table 283. Brazil Fosfomycin Sodium, by End-User USD Million (2025-2030)
  • Table 284. Argentina Fosfomycin Sodium, by Type USD Million (2025-2030)
  • Table 285. Argentina Fosfomycin Sodium, by Application USD Million (2025-2030)
  • Table 286. Argentina Fosfomycin Sodium, by Distribution Channel USD Million (2025-2030)
  • Table 287. Argentina Fosfomycin Sodium, by End-User USD Million (2025-2030)
  • Table 288. Rest of South America Fosfomycin Sodium, by Type USD Million (2025-2030)
  • Table 289. Rest of South America Fosfomycin Sodium, by Application USD Million (2025-2030)
  • Table 290. Rest of South America Fosfomycin Sodium, by Distribution Channel USD Million (2025-2030)
  • Table 291. Rest of South America Fosfomycin Sodium, by End-User USD Million (2025-2030)
  • Table 292. Asia Pacific Fosfomycin Sodium, by Country USD Million (2025-2030)
  • Table 293. Asia Pacific Fosfomycin Sodium, by Type USD Million (2025-2030)
  • Table 294. Asia Pacific Fosfomycin Sodium, by Application USD Million (2025-2030)
  • Table 295. Asia Pacific Fosfomycin Sodium, by Distribution Channel USD Million (2025-2030)
  • Table 296. Asia Pacific Fosfomycin Sodium, by End-User USD Million (2025-2030)
  • Table 297. China Fosfomycin Sodium, by Type USD Million (2025-2030)
  • Table 298. China Fosfomycin Sodium, by Application USD Million (2025-2030)
  • Table 299. China Fosfomycin Sodium, by Distribution Channel USD Million (2025-2030)
  • Table 300. China Fosfomycin Sodium, by End-User USD Million (2025-2030)
  • Table 301. Japan Fosfomycin Sodium, by Type USD Million (2025-2030)
  • Table 302. Japan Fosfomycin Sodium, by Application USD Million (2025-2030)
  • Table 303. Japan Fosfomycin Sodium, by Distribution Channel USD Million (2025-2030)
  • Table 304. Japan Fosfomycin Sodium, by End-User USD Million (2025-2030)
  • Table 305. India Fosfomycin Sodium, by Type USD Million (2025-2030)
  • Table 306. India Fosfomycin Sodium, by Application USD Million (2025-2030)
  • Table 307. India Fosfomycin Sodium, by Distribution Channel USD Million (2025-2030)
  • Table 308. India Fosfomycin Sodium, by End-User USD Million (2025-2030)
  • Table 309. South Korea Fosfomycin Sodium, by Type USD Million (2025-2030)
  • Table 310. South Korea Fosfomycin Sodium, by Application USD Million (2025-2030)
  • Table 311. South Korea Fosfomycin Sodium, by Distribution Channel USD Million (2025-2030)
  • Table 312. South Korea Fosfomycin Sodium, by End-User USD Million (2025-2030)
  • Table 313. Taiwan Fosfomycin Sodium, by Type USD Million (2025-2030)
  • Table 314. Taiwan Fosfomycin Sodium, by Application USD Million (2025-2030)
  • Table 315. Taiwan Fosfomycin Sodium, by Distribution Channel USD Million (2025-2030)
  • Table 316. Taiwan Fosfomycin Sodium, by End-User USD Million (2025-2030)
  • Table 317. Australia Fosfomycin Sodium, by Type USD Million (2025-2030)
  • Table 318. Australia Fosfomycin Sodium, by Application USD Million (2025-2030)
  • Table 319. Australia Fosfomycin Sodium, by Distribution Channel USD Million (2025-2030)
  • Table 320. Australia Fosfomycin Sodium, by End-User USD Million (2025-2030)
  • Table 321. Rest of Asia-Pacific Fosfomycin Sodium, by Type USD Million (2025-2030)
  • Table 322. Rest of Asia-Pacific Fosfomycin Sodium, by Application USD Million (2025-2030)
  • Table 323. Rest of Asia-Pacific Fosfomycin Sodium, by Distribution Channel USD Million (2025-2030)
  • Table 324. Rest of Asia-Pacific Fosfomycin Sodium, by End-User USD Million (2025-2030)
  • Table 325. Europe Fosfomycin Sodium, by Country USD Million (2025-2030)
  • Table 326. Europe Fosfomycin Sodium, by Type USD Million (2025-2030)
  • Table 327. Europe Fosfomycin Sodium, by Application USD Million (2025-2030)
  • Table 328. Europe Fosfomycin Sodium, by Distribution Channel USD Million (2025-2030)
  • Table 329. Europe Fosfomycin Sodium, by End-User USD Million (2025-2030)
  • Table 330. Germany Fosfomycin Sodium, by Type USD Million (2025-2030)
  • Table 331. Germany Fosfomycin Sodium, by Application USD Million (2025-2030)
  • Table 332. Germany Fosfomycin Sodium, by Distribution Channel USD Million (2025-2030)
  • Table 333. Germany Fosfomycin Sodium, by End-User USD Million (2025-2030)
  • Table 334. France Fosfomycin Sodium, by Type USD Million (2025-2030)
  • Table 335. France Fosfomycin Sodium, by Application USD Million (2025-2030)
  • Table 336. France Fosfomycin Sodium, by Distribution Channel USD Million (2025-2030)
  • Table 337. France Fosfomycin Sodium, by End-User USD Million (2025-2030)
  • Table 338. Italy Fosfomycin Sodium, by Type USD Million (2025-2030)
  • Table 339. Italy Fosfomycin Sodium, by Application USD Million (2025-2030)
  • Table 340. Italy Fosfomycin Sodium, by Distribution Channel USD Million (2025-2030)
  • Table 341. Italy Fosfomycin Sodium, by End-User USD Million (2025-2030)
  • Table 342. United Kingdom Fosfomycin Sodium, by Type USD Million (2025-2030)
  • Table 343. United Kingdom Fosfomycin Sodium, by Application USD Million (2025-2030)
  • Table 344. United Kingdom Fosfomycin Sodium, by Distribution Channel USD Million (2025-2030)
  • Table 345. United Kingdom Fosfomycin Sodium, by End-User USD Million (2025-2030)
  • Table 346. Netherlands Fosfomycin Sodium, by Type USD Million (2025-2030)
  • Table 347. Netherlands Fosfomycin Sodium, by Application USD Million (2025-2030)
  • Table 348. Netherlands Fosfomycin Sodium, by Distribution Channel USD Million (2025-2030)
  • Table 349. Netherlands Fosfomycin Sodium, by End-User USD Million (2025-2030)
  • Table 350. Rest of Europe Fosfomycin Sodium, by Type USD Million (2025-2030)
  • Table 351. Rest of Europe Fosfomycin Sodium, by Application USD Million (2025-2030)
  • Table 352. Rest of Europe Fosfomycin Sodium, by Distribution Channel USD Million (2025-2030)
  • Table 353. Rest of Europe Fosfomycin Sodium, by End-User USD Million (2025-2030)
  • Table 354. MEA Fosfomycin Sodium, by Country USD Million (2025-2030)
  • Table 355. MEA Fosfomycin Sodium, by Type USD Million (2025-2030)
  • Table 356. MEA Fosfomycin Sodium, by Application USD Million (2025-2030)
  • Table 357. MEA Fosfomycin Sodium, by Distribution Channel USD Million (2025-2030)
  • Table 358. MEA Fosfomycin Sodium, by End-User USD Million (2025-2030)
  • Table 359. Middle East Fosfomycin Sodium, by Type USD Million (2025-2030)
  • Table 360. Middle East Fosfomycin Sodium, by Application USD Million (2025-2030)
  • Table 361. Middle East Fosfomycin Sodium, by Distribution Channel USD Million (2025-2030)
  • Table 362. Middle East Fosfomycin Sodium, by End-User USD Million (2025-2030)
  • Table 363. Africa Fosfomycin Sodium, by Type USD Million (2025-2030)
  • Table 364. Africa Fosfomycin Sodium, by Application USD Million (2025-2030)
  • Table 365. Africa Fosfomycin Sodium, by Distribution Channel USD Million (2025-2030)
  • Table 366. Africa Fosfomycin Sodium, by End-User USD Million (2025-2030)
  • Table 367. North America Fosfomycin Sodium, by Country USD Million (2025-2030)
  • Table 368. North America Fosfomycin Sodium, by Type USD Million (2025-2030)
  • Table 369. North America Fosfomycin Sodium, by Application USD Million (2025-2030)
  • Table 370. North America Fosfomycin Sodium, by Distribution Channel USD Million (2025-2030)
  • Table 371. North America Fosfomycin Sodium, by End-User USD Million (2025-2030)
  • Table 372. United States Fosfomycin Sodium, by Type USD Million (2025-2030)
  • Table 373. United States Fosfomycin Sodium, by Application USD Million (2025-2030)
  • Table 374. United States Fosfomycin Sodium, by Distribution Channel USD Million (2025-2030)
  • Table 375. United States Fosfomycin Sodium, by End-User USD Million (2025-2030)
  • Table 376. Canada Fosfomycin Sodium, by Type USD Million (2025-2030)
  • Table 377. Canada Fosfomycin Sodium, by Application USD Million (2025-2030)
  • Table 378. Canada Fosfomycin Sodium, by Distribution Channel USD Million (2025-2030)
  • Table 379. Canada Fosfomycin Sodium, by End-User USD Million (2025-2030)
  • Table 380. Mexico Fosfomycin Sodium, by Type USD Million (2025-2030)
  • Table 381. Mexico Fosfomycin Sodium, by Application USD Million (2025-2030)
  • Table 382. Mexico Fosfomycin Sodium, by Distribution Channel USD Million (2025-2030)
  • Table 383. Mexico Fosfomycin Sodium, by End-User USD Million (2025-2030)
  • Table 384. Fosfomycin Sodium Sales: by Type(K Tons)
  • Table 385. Fosfomycin Sodium Sales Tablets , by Region K Tons (2025-2030)
  • Table 386. Fosfomycin Sodium Sales Injection , by Region K Tons (2025-2030)
  • Table 387. Fosfomycin Sodium Sales: by Application(K Tons)
  • Table 388. Fosfomycin Sodium Sales Common Urinary Tract Infection , by Region K Tons (2025-2030)
  • Table 389. Fosfomycin Sodium Sales Postoperative Urinary Tract Infection , by Region K Tons (2025-2030)
  • Table 390. Fosfomycin Sodium Sales Preoperative Prevention of Urinary Tract Infection , by Region K Tons (2025-2030)
  • Table 391. Fosfomycin Sodium Sales: by Distribution Channel(K Tons)
  • Table 392. Fosfomycin Sodium Sales Online , by Region K Tons (2025-2030)
  • Table 393. Fosfomycin Sodium Sales Medical Stores , by Region K Tons (2025-2030)
  • Table 394. Fosfomycin Sodium Sales Pharmaceuticals , by Region K Tons (2025-2030)
  • Table 395. Fosfomycin Sodium Sales: by End-User(K Tons)
  • Table 396. Fosfomycin Sodium Sales Hospital Pharmacy , by Region K Tons (2025-2030)
  • Table 397. Fosfomycin Sodium Sales Retail Pharmacies , by Region K Tons (2025-2030)
  • Table 398. Fosfomycin Sodium Sales Electronic Pharmacy , by Region K Tons (2025-2030)
  • Table 399. South America Fosfomycin Sodium Sales, by Country K Tons (2025-2030)
  • Table 400. South America Fosfomycin Sodium Sales, by Type K Tons (2025-2030)
  • Table 401. South America Fosfomycin Sodium Sales, by Application K Tons (2025-2030)
  • Table 402. South America Fosfomycin Sodium Sales, by Distribution Channel K Tons (2025-2030)
  • Table 403. South America Fosfomycin Sodium Sales, by End-User K Tons (2025-2030)
  • Table 404. Brazil Fosfomycin Sodium Sales, by Type K Tons (2025-2030)
  • Table 405. Brazil Fosfomycin Sodium Sales, by Application K Tons (2025-2030)
  • Table 406. Brazil Fosfomycin Sodium Sales, by Distribution Channel K Tons (2025-2030)
  • Table 407. Brazil Fosfomycin Sodium Sales, by End-User K Tons (2025-2030)
  • Table 408. Argentina Fosfomycin Sodium Sales, by Type K Tons (2025-2030)
  • Table 409. Argentina Fosfomycin Sodium Sales, by Application K Tons (2025-2030)
  • Table 410. Argentina Fosfomycin Sodium Sales, by Distribution Channel K Tons (2025-2030)
  • Table 411. Argentina Fosfomycin Sodium Sales, by End-User K Tons (2025-2030)
  • Table 412. Rest of South America Fosfomycin Sodium Sales, by Type K Tons (2025-2030)
  • Table 413. Rest of South America Fosfomycin Sodium Sales, by Application K Tons (2025-2030)
  • Table 414. Rest of South America Fosfomycin Sodium Sales, by Distribution Channel K Tons (2025-2030)
  • Table 415. Rest of South America Fosfomycin Sodium Sales, by End-User K Tons (2025-2030)
  • Table 416. Asia Pacific Fosfomycin Sodium Sales, by Country K Tons (2025-2030)
  • Table 417. Asia Pacific Fosfomycin Sodium Sales, by Type K Tons (2025-2030)
  • Table 418. Asia Pacific Fosfomycin Sodium Sales, by Application K Tons (2025-2030)
  • Table 419. Asia Pacific Fosfomycin Sodium Sales, by Distribution Channel K Tons (2025-2030)
  • Table 420. Asia Pacific Fosfomycin Sodium Sales, by End-User K Tons (2025-2030)
  • Table 421. China Fosfomycin Sodium Sales, by Type K Tons (2025-2030)
  • Table 422. China Fosfomycin Sodium Sales, by Application K Tons (2025-2030)
  • Table 423. China Fosfomycin Sodium Sales, by Distribution Channel K Tons (2025-2030)
  • Table 424. China Fosfomycin Sodium Sales, by End-User K Tons (2025-2030)
  • Table 425. Japan Fosfomycin Sodium Sales, by Type K Tons (2025-2030)
  • Table 426. Japan Fosfomycin Sodium Sales, by Application K Tons (2025-2030)
  • Table 427. Japan Fosfomycin Sodium Sales, by Distribution Channel K Tons (2025-2030)
  • Table 428. Japan Fosfomycin Sodium Sales, by End-User K Tons (2025-2030)
  • Table 429. India Fosfomycin Sodium Sales, by Type K Tons (2025-2030)
  • Table 430. India Fosfomycin Sodium Sales, by Application K Tons (2025-2030)
  • Table 431. India Fosfomycin Sodium Sales, by Distribution Channel K Tons (2025-2030)
  • Table 432. India Fosfomycin Sodium Sales, by End-User K Tons (2025-2030)
  • Table 433. South Korea Fosfomycin Sodium Sales, by Type K Tons (2025-2030)
  • Table 434. South Korea Fosfomycin Sodium Sales, by Application K Tons (2025-2030)
  • Table 435. South Korea Fosfomycin Sodium Sales, by Distribution Channel K Tons (2025-2030)
  • Table 436. South Korea Fosfomycin Sodium Sales, by End-User K Tons (2025-2030)
  • Table 437. Taiwan Fosfomycin Sodium Sales, by Type K Tons (2025-2030)
  • Table 438. Taiwan Fosfomycin Sodium Sales, by Application K Tons (2025-2030)
  • Table 439. Taiwan Fosfomycin Sodium Sales, by Distribution Channel K Tons (2025-2030)
  • Table 440. Taiwan Fosfomycin Sodium Sales, by End-User K Tons (2025-2030)
  • Table 441. Australia Fosfomycin Sodium Sales, by Type K Tons (2025-2030)
  • Table 442. Australia Fosfomycin Sodium Sales, by Application K Tons (2025-2030)
  • Table 443. Australia Fosfomycin Sodium Sales, by Distribution Channel K Tons (2025-2030)
  • Table 444. Australia Fosfomycin Sodium Sales, by End-User K Tons (2025-2030)
  • Table 445. Rest of Asia-Pacific Fosfomycin Sodium Sales, by Type K Tons (2025-2030)
  • Table 446. Rest of Asia-Pacific Fosfomycin Sodium Sales, by Application K Tons (2025-2030)
  • Table 447. Rest of Asia-Pacific Fosfomycin Sodium Sales, by Distribution Channel K Tons (2025-2030)
  • Table 448. Rest of Asia-Pacific Fosfomycin Sodium Sales, by End-User K Tons (2025-2030)
  • Table 449. Europe Fosfomycin Sodium Sales, by Country K Tons (2025-2030)
  • Table 450. Europe Fosfomycin Sodium Sales, by Type K Tons (2025-2030)
  • Table 451. Europe Fosfomycin Sodium Sales, by Application K Tons (2025-2030)
  • Table 452. Europe Fosfomycin Sodium Sales, by Distribution Channel K Tons (2025-2030)
  • Table 453. Europe Fosfomycin Sodium Sales, by End-User K Tons (2025-2030)
  • Table 454. Germany Fosfomycin Sodium Sales, by Type K Tons (2025-2030)
  • Table 455. Germany Fosfomycin Sodium Sales, by Application K Tons (2025-2030)
  • Table 456. Germany Fosfomycin Sodium Sales, by Distribution Channel K Tons (2025-2030)
  • Table 457. Germany Fosfomycin Sodium Sales, by End-User K Tons (2025-2030)
  • Table 458. France Fosfomycin Sodium Sales, by Type K Tons (2025-2030)
  • Table 459. France Fosfomycin Sodium Sales, by Application K Tons (2025-2030)
  • Table 460. France Fosfomycin Sodium Sales, by Distribution Channel K Tons (2025-2030)
  • Table 461. France Fosfomycin Sodium Sales, by End-User K Tons (2025-2030)
  • Table 462. Italy Fosfomycin Sodium Sales, by Type K Tons (2025-2030)
  • Table 463. Italy Fosfomycin Sodium Sales, by Application K Tons (2025-2030)
  • Table 464. Italy Fosfomycin Sodium Sales, by Distribution Channel K Tons (2025-2030)
  • Table 465. Italy Fosfomycin Sodium Sales, by End-User K Tons (2025-2030)
  • Table 466. United Kingdom Fosfomycin Sodium Sales, by Type K Tons (2025-2030)
  • Table 467. United Kingdom Fosfomycin Sodium Sales, by Application K Tons (2025-2030)
  • Table 468. United Kingdom Fosfomycin Sodium Sales, by Distribution Channel K Tons (2025-2030)
  • Table 469. United Kingdom Fosfomycin Sodium Sales, by End-User K Tons (2025-2030)
  • Table 470. Netherlands Fosfomycin Sodium Sales, by Type K Tons (2025-2030)
  • Table 471. Netherlands Fosfomycin Sodium Sales, by Application K Tons (2025-2030)
  • Table 472. Netherlands Fosfomycin Sodium Sales, by Distribution Channel K Tons (2025-2030)
  • Table 473. Netherlands Fosfomycin Sodium Sales, by End-User K Tons (2025-2030)
  • Table 474. Rest of Europe Fosfomycin Sodium Sales, by Type K Tons (2025-2030)
  • Table 475. Rest of Europe Fosfomycin Sodium Sales, by Application K Tons (2025-2030)
  • Table 476. Rest of Europe Fosfomycin Sodium Sales, by Distribution Channel K Tons (2025-2030)
  • Table 477. Rest of Europe Fosfomycin Sodium Sales, by End-User K Tons (2025-2030)
  • Table 478. MEA Fosfomycin Sodium Sales, by Country K Tons (2025-2030)
  • Table 479. MEA Fosfomycin Sodium Sales, by Type K Tons (2025-2030)
  • Table 480. MEA Fosfomycin Sodium Sales, by Application K Tons (2025-2030)
  • Table 481. MEA Fosfomycin Sodium Sales, by Distribution Channel K Tons (2025-2030)
  • Table 482. MEA Fosfomycin Sodium Sales, by End-User K Tons (2025-2030)
  • Table 483. Middle East Fosfomycin Sodium Sales, by Type K Tons (2025-2030)
  • Table 484. Middle East Fosfomycin Sodium Sales, by Application K Tons (2025-2030)
  • Table 485. Middle East Fosfomycin Sodium Sales, by Distribution Channel K Tons (2025-2030)
  • Table 486. Middle East Fosfomycin Sodium Sales, by End-User K Tons (2025-2030)
  • Table 487. Africa Fosfomycin Sodium Sales, by Type K Tons (2025-2030)
  • Table 488. Africa Fosfomycin Sodium Sales, by Application K Tons (2025-2030)
  • Table 489. Africa Fosfomycin Sodium Sales, by Distribution Channel K Tons (2025-2030)
  • Table 490. Africa Fosfomycin Sodium Sales, by End-User K Tons (2025-2030)
  • Table 491. North America Fosfomycin Sodium Sales, by Country K Tons (2025-2030)
  • Table 492. North America Fosfomycin Sodium Sales, by Type K Tons (2025-2030)
  • Table 493. North America Fosfomycin Sodium Sales, by Application K Tons (2025-2030)
  • Table 494. North America Fosfomycin Sodium Sales, by Distribution Channel K Tons (2025-2030)
  • Table 495. North America Fosfomycin Sodium Sales, by End-User K Tons (2025-2030)
  • Table 496. United States Fosfomycin Sodium Sales, by Type K Tons (2025-2030)
  • Table 497. United States Fosfomycin Sodium Sales, by Application K Tons (2025-2030)
  • Table 498. United States Fosfomycin Sodium Sales, by Distribution Channel K Tons (2025-2030)
  • Table 499. United States Fosfomycin Sodium Sales, by End-User K Tons (2025-2030)
  • Table 500. Canada Fosfomycin Sodium Sales, by Type K Tons (2025-2030)
  • Table 501. Canada Fosfomycin Sodium Sales, by Application K Tons (2025-2030)
  • Table 502. Canada Fosfomycin Sodium Sales, by Distribution Channel K Tons (2025-2030)
  • Table 503. Canada Fosfomycin Sodium Sales, by End-User K Tons (2025-2030)
  • Table 504. Mexico Fosfomycin Sodium Sales, by Type K Tons (2025-2030)
  • Table 505. Mexico Fosfomycin Sodium Sales, by Application K Tons (2025-2030)
  • Table 506. Mexico Fosfomycin Sodium Sales, by Distribution Channel K Tons (2025-2030)
  • Table 507. Mexico Fosfomycin Sodium Sales, by End-User K Tons (2025-2030)
  • Table 508. Fosfomycin Sodium: by Type(USD/Units)
  • Table 509. Research Programs/Design for This Report
  • Table 510. Key Data Information from Secondary Sources
  • Table 511. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Fosfomycin Sodium: by Type USD Million (2018-2023)
  • Figure 5. Global Fosfomycin Sodium: by Application USD Million (2018-2023)
  • Figure 6. Global Fosfomycin Sodium: by Distribution Channel USD Million (2018-2023)
  • Figure 7. Global Fosfomycin Sodium: by End-User USD Million (2018-2023)
  • Figure 8. South America Fosfomycin Sodium Share (%), by Country
  • Figure 9. Asia Pacific Fosfomycin Sodium Share (%), by Country
  • Figure 10. Europe Fosfomycin Sodium Share (%), by Country
  • Figure 11. MEA Fosfomycin Sodium Share (%), by Country
  • Figure 12. North America Fosfomycin Sodium Share (%), by Country
  • Figure 13. Global Fosfomycin Sodium: by Type K Tons (2018-2023)
  • Figure 14. Global Fosfomycin Sodium: by Application K Tons (2018-2023)
  • Figure 15. Global Fosfomycin Sodium: by Distribution Channel K Tons (2018-2023)
  • Figure 16. Global Fosfomycin Sodium: by End-User K Tons (2018-2023)
  • Figure 17. South America Fosfomycin Sodium Share (%), by Country
  • Figure 18. Asia Pacific Fosfomycin Sodium Share (%), by Country
  • Figure 19. Europe Fosfomycin Sodium Share (%), by Country
  • Figure 20. MEA Fosfomycin Sodium Share (%), by Country
  • Figure 21. North America Fosfomycin Sodium Share (%), by Country
  • Figure 22. Global Fosfomycin Sodium: by Type USD/Units (2018-2023)
  • Figure 23. Global Fosfomycin Sodium share by Players 2023 (%)
  • Figure 24. Global Fosfomycin Sodium share by Players (Top 3) 2023(%)
  • Figure 25. Global Fosfomycin Sodium share by Players (Top 5) 2023(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. Merck Group (Germany) Revenue, Net Income and Gross profit
  • Figure 28. Merck Group (Germany) Revenue: by Geography 2023
  • Figure 29. AdvaCare Pharma (United States) Revenue, Net Income and Gross profit
  • Figure 30. AdvaCare Pharma (United States) Revenue: by Geography 2023
  • Figure 31. LGM Pharma (United States) Revenue, Net Income and Gross profit
  • Figure 32. LGM Pharma (United States) Revenue: by Geography 2023
  • Figure 33. Cipla (India) Revenue, Net Income and Gross profit
  • Figure 34. Cipla (India) Revenue: by Geography 2023
  • Figure 35. Northeast Pharmaceutical Group Co. Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 36. Northeast Pharmaceutical Group Co. Ltd. (China) Revenue: by Geography 2023
  • Figure 37. Ercros (Spain) Revenue, Net Income and Gross profit
  • Figure 38. Ercros (Spain) Revenue: by Geography 2023
  • Figure 39. SGPharma Pvt. Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 40. SGPharma Pvt. Ltd. (India) Revenue: by Geography 2023
  • Figure 41. Shin Poong Pharm Co. Ltd. (South Korea) Revenue, Net Income and Gross profit
  • Figure 42. Shin Poong Pharm Co. Ltd. (South Korea) Revenue: by Geography 2023
  • Figure 43. Sundent Pharm Group (China) Revenue, Net Income and Gross profit
  • Figure 44. Sundent Pharm Group (China) Revenue: by Geography 2023
  • Figure 45. Hubei Xunda Pharmaceutical (China) Revenue, Net Income and Gross profit
  • Figure 46. Hubei Xunda Pharmaceutical (China) Revenue: by Geography 2023
  • Figure 47. Global Fosfomycin Sodium: by Type USD Million (2025-2030)
  • Figure 48. Global Fosfomycin Sodium: by Application USD Million (2025-2030)
  • Figure 49. Global Fosfomycin Sodium: by Distribution Channel USD Million (2025-2030)
  • Figure 50. Global Fosfomycin Sodium: by End-User USD Million (2025-2030)
  • Figure 51. South America Fosfomycin Sodium Share (%), by Country
  • Figure 52. Asia Pacific Fosfomycin Sodium Share (%), by Country
  • Figure 53. Europe Fosfomycin Sodium Share (%), by Country
  • Figure 54. MEA Fosfomycin Sodium Share (%), by Country
  • Figure 55. North America Fosfomycin Sodium Share (%), by Country
  • Figure 56. Global Fosfomycin Sodium: by Type K Tons (2025-2030)
  • Figure 57. Global Fosfomycin Sodium: by Application K Tons (2025-2030)
  • Figure 58. Global Fosfomycin Sodium: by Distribution Channel K Tons (2025-2030)
  • Figure 59. Global Fosfomycin Sodium: by End-User K Tons (2025-2030)
  • Figure 60. South America Fosfomycin Sodium Share (%), by Country
  • Figure 61. Asia Pacific Fosfomycin Sodium Share (%), by Country
  • Figure 62. Europe Fosfomycin Sodium Share (%), by Country
  • Figure 63. MEA Fosfomycin Sodium Share (%), by Country
  • Figure 64. North America Fosfomycin Sodium Share (%), by Country
  • Figure 65. Global Fosfomycin Sodium: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Merck Group (Germany)
  • AdvaCare Pharma (United States)
  • LGM Pharma (United States)
  • Cipla (India)
  • Northeast Pharmaceutical Group Co. Ltd. (China)
  • Ercros (Spain)
  • SGPharma Pvt. Ltd. (India)
  • Shin Poong Pharm Co. Ltd. (South Korea)
  • Sundent Pharm Group (China)
  • Hubei Xunda Pharmaceutical (China)
Additional players considered in the study are as follows:
FarmaSino Pharmaceutical (China) , National Analytical Corporation (India)
Select User Access Type

Key Highlights of Report


Feb 2024 202 Pages 86 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Fosfomycin Sodium Market Quantitative research analysis
Global Fosfomycin Sodium Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The prominent players of Global Fosfomycin Sodium market are Merck Group (Germany), AdvaCare Pharma (United States), LGM Pharma (United States), Cipla (India), Northeast Pharmaceutical Group Co. Ltd. (China), Ercros (Spain), SGPharma Pvt. Ltd. (India), Shin Poong Pharm Co. Ltd. (South Korea), Sundent Pharm Group (China) and Hubei Xunda Pharmaceutical (China).
In this highly competitive & fast evolving Fosfomycin Sodium industry, the top strategic priorities would remain consistent like innovation, R&D, and M&A.
Common Urinary Tract Infection, Postoperative Urinary Tract Infection and Preoperative Prevention of Urinary Tract Infection are the potential customers of Fosfomycin Sodium industry.
The Global Fosfomycin Sodium market is expected to see a growth of 3.6% during projected year 2023 to 2030.

Know More About Global Fosfomycin Sodium Market Report?

Have a Query? Click Here

Other Related Reports

Clarithromycin Tablets Comprehensive Study by Type (250 mg Tablets, 500 mg Tablets), Application (Dermatology, ENT, Pediatric, Thoracic and Cardiovascular, Pulmonary Medicine), Distribution Channel (...
$ 3350
D-Calcium Pantothenate Comprehensive Study by Type (Food Grade, Pharma Grade, Feed Grade), Application (Food Industry, Cosmetic Industry, Pharmaceuticals Industry, Feed Industry, Other) Players and R...
$ 3500
Neuropathic Pain Management Comprehensive Study by Type (Tricyclic Antidepressant, Anticonvulsant, Opioid, Steroid Drug, Local Anesthesia, Other), Application (Hospitals, Clinics, Research Organizati...
$ 3750
Human Coagulation Comprehensive Study by Type (Instruments, Consumables), Application (Hospitals, Clinical Laboratories, Others), Functioning of Factors (II, VII, Others) Players and Region - Asia-Pa...
$ 3500
Tetrahydrocannabinol Comprehensive Study by Application (Chronic Pain, Mental Disorders, Arthritis, Migraine, Cancer, Other), Distribution Channel (Hospital Pharmacy, Dispensaries, Online Pharmacy) P...
$ 3500
Dermatology Drugs Comprehensive Study by Type (Prescription-Based Drugs, Over-the-Counter Drugs), Application (Psoriasis, Skin Infections, Acne, Dermatitis, Other), Forms (Tablets, External Use, Inje...
$ 3500